Poxel S.A. (EPA:POXEL)
0.2020
-0.0075 (-3.58%)
Aug 3, 2026, 1:50 PM CET
Poxel Revenue
Poxel had revenue of 2.18M EUR in the half year ending June 30, 2025, with 128.59% growth. This brings the company's revenue in the last twelve months to 7.66M, up 249.95% year-over-year. In the year 2024, Poxel had annual revenue of 6.64M with 234.98% growth.
Revenue (ttm)
7.66M
Revenue Growth
+249.95%
P/S Ratio
1.47
Revenue / Employee
1.53M
Employees
5
Market Cap
11.26M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.64M | 4.66M | 234.98% |
| Dec 31, 2023 | 1.98M | 1.31M | 193.92% |
| Dec 31, 2022 | 674.00K | -15.75M | -95.90% |
| Dec 31, 2021 | 16.43M | 9.62M | 141.33% |
| Dec 31, 2020 | 6.81M | -19.75M | -74.37% |
| Dec 31, 2019 | 26.56M | -35.82M | -57.43% |
| Dec 31, 2018 | 62.38M | 57.09M | 1,079.22% |
| Dec 31, 2017 | 5.29M | 5.22M | 7,428.64% |
| Dec 31, 2016 | 70.27K | 10.62K | 17.80% |
| Dec 31, 2015 | 59.65K | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| genOway Société anonyme | 28.60M |
| Nicox | 16.77M |
| Advicenne | 6.40M |
| Aelis Farma | 2.08M |
| Oncodesign Precision Medicine Société anonyme | 1.81M |
| Plant Advanced Technologies | 1.65M |
| Aton | 656.93K |
| GenSight Biologics | 652.00K |
Poxel News
- 3 days ago - Poxel Earnings release: Q2 2026 - Filings
- 7 weeks ago - Poxel Appoints Yves Decadt as Chief Executive Officer to Accelerate Portfolio Development and Strategic Partnerships - Business Wire
- 2 months ago - Poxel Reports First Quarter 2026 Revenue and Provides a Business Update - Business Wire
- 2 months ago - Poxel Earnings release: Q1 2026 - Filings
- 3 months ago - Poxel: Postponement of the Publication of the 2025 Annual Financial Statements and the Annual Financial Report - Business Wire
- 4 months ago - Poxel To Sell PXL770 To Scynexis For Up To $196 Mln; Shares Up - Nasdaq
- 4 months ago - Poxel announces sale of PXL770 to Scynexis for up to $196M - TheFly
- 4 months ago - Poxel Confirms the Drawdown Under the Additional Tranche D PDR Bond Issue as Part of the Continuation Plan - Business Wire